Structure Therapeutics GPCR
NASDAQ GPCR
$32.69 -2.38 (-6.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Liabilities and Shareholders Equity (2022 - 2026)

Updated

Structure Therapeutics' Liabilities and Shareholders Equity came in at $1.43 billion for Q2 2026, up 74.6% from $816.44 million a year earlier but down 5.5% from the prior quarter.

Analysis

Structure Therapeutics (GPCR) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, Structure Therapeutics' Liabilities and Shareholders Equity was $1.58 billion, up 75.3% from FY2024.

  • Liabilities and Shareholders Equity has increased in each of the last three years, with a three-year compound annual growth rate of 153.0% (FY2022 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $903.33 million in FY2024 (+87.4%), $482.02 million in FY2023 (+392.6%) and $97.85 million in FY2022.
  • The five-year range for quarterly Liabilities and Shareholders Equity is $97.85 million (Q4 2022) to $1.58 billion (Q4 2025).
  • Year-over-year, Liabilities and Shareholders Equity has increased for three consecutive quarters, with growth averaging 88.4% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2023 (growth of 392.6%), and the weakest in Q2 2025 (a decline of 13.8%).
  • Business Quant data shows GPCR's Liabilities and Shareholders Equity at $1.51 billion (Q1 2026), $1.58 billion (Q4 2025) and $832.16 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Structure Therapeutics 7.49 Bn 7.49 Bn - 1.43 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Bn
Mar 31, 2026 1.51 Bn
Dec 31, 2025 1.58 Bn
Sep 30, 2025 832.16 Mn
Jun 30, 2025 816.44 Mn
Mar 31, 2025 866.55 Mn
Dec 31, 2024 903.33 Mn
Sep 30, 2024 933.22 Mn
Jun 30, 2024 947.03 Mn
Mar 31, 2024 457.23 Mn
Dec 31, 2023 482.02 Mn
Sep 30, 2023 216.37 Mn
Jun 30, 2023 229.43 Mn
Mar 31, 2023 247.35 Mn
Dec 31, 2022 97.85 Mn
API Access

Structure Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GPCR&period=max&api_key=YOUR_API_KEY